DMRA News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2026-07-20 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 1.01,3.03,5.03,7.01,9.01. |
| 2026-06-17 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2026-05-04 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 5.02,9.01. |
| 2026-04-20 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 4.01,9.01. |
| 2026-03-23 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2026-03-10 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 2.02,5.03,7.01,9.01. |
| 2026-02-11 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 1.01,9.01. |
| 2026-02-10 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 5.02,5.03,8.01,9.01. |
| 2026-01-12 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2026-01-06 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 3.02,5.02,9.01. |
| 2025-12-09 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K/A | Damora Therapeutics, Inc. filed Form 8-K/A covering items 5.03,9.01. |
| 2025-11-10 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 1.01,2.01,3.02,5.02,5.03,7.01,9.01. |
| 2025-06-20 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2024-10-15 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 5.02,9.01. |
| 2024-10-07 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 1.01,2.01,3.02,5.02,5.03,7.01,9.01. |
| 2024-09-18 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 8.01. |
| 2024-09-11 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 8.01. |
| 2024-09-05 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 5.03,9.01. |
| 2024-06-21 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2024-03-26 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 8.01. |
| 2023-12-21 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2023-10-23 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2023-10-02 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 3.01. |
| 2023-09-26 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 2.05,5.02,8.01,9.01. |
| 2023-08-15 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 7.01,8.01,9.01. |
| 2023-06-15 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2023-03-10 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 7.01. |
| 2023-01-06 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 2.02,7.01,9.01. |
| 2022-10-31 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2022-09-29 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 7.01,8.01,9.01. |
| 2022-06-17 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2022-02-09 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 5.02,9.01. |
| 2022-01-27 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2022-01-05 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2021-07-06 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 5.02,9.01. |
| 2021-05-28 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 5.07. |
| 2021-03-15 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2021-01-08 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 5.02,9.01. |
| 2021-01-05 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 2.02,7.01,9.01. |
| 2020-11-23 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 5.02,9.01. |
| 2020-11-04 | Current report | SEC filing | Damora Therapeutics, Inc. filed Form 8-K | Damora Therapeutics, Inc. filed Form 8-K covering items 5.03,9.01. |